News & Perspective

Mar 16, 2017

Mar 16, 2017
NIH researcher

Trump's budget cuts 20% of NIH; groups express outrage

The budget supports earlier commitment to Gavi vaccine initiatives but dials back funds for other global health efforts.

Jan 28, 2011

Jan 28, 2011

Experts air kinks in antiviral use during H1N1 pandemic

(CIDRAP News) – Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.

Jan 20, 2011

Jan 20, 2011

Study: Plasma from former H1N1 patients saved lives

(CIDRAP News) – A report from Hong Kong says that the use of blood plasma donated by recovered H1N1 influenza patients reduced the death rate in severely ill H1N1 patients.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 02, 2007

Nov 02, 2007

THE PANDEMIC VACCINE PUZZLE Part 7: Time for a vaccine 'Manhattan Project'?

Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Oct 13, 2006

Oct 13, 2006

Study supports concept of 2-stage H5N1 vaccination

(CIDRAP News) – The human immune system may respond better to a vaccine for a new strain of H5N1 avian influenza if it is prepared in advance with a vaccine based on an existing H5N1 strain, the preliminary results of a government-sponsored study suggest.

Oct 04, 2006

Oct 04, 2006

Groups call for pandemic flu vaccine 'master plan'

(CIDRAP News) – Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.

Jun 17, 2005

Jun 17, 2005

IDSA says US antiviral supply for flu falls far short

(CIDRAP News) – The Infectious Diseases Society of America (IDSA) is calling the US government's stockpile of antiviral drugs "totally inadequate" in the face of a potential influenza pandemic.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»